Lyndsey Crowe Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1201 W Center St, Beebe, AR 72012 Phone: 501-882-5463 |
Mrs. Lesley Ann Barry, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Beebe, AR 72012 Phone: 501-882-3852 |
Mrs. Wendy L. Clark, MSCCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Beebe, AR 72012 Phone: 501-882-3852 |
Katherine Amelia Kuykendall, M.C.D., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 114 N Main St, Beebe, AR 72012 Phone: 501-882-5467 |
Mrs. Kristy Dawn Poe, MS, CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2233 Highway 31 N, Beebe, AR 72012 Phone: 501-882-5605 |
Ms. Kerry Lynne Guyot, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 133 N Main St, Beebe, AR 72012 Phone: 501-882-3852 |
Danielle Shock Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Wilbur Mills Coop, 114 N Main, Beebe, AR 72012 Phone: 501-882-3852 Fax: 501-882-1025 |
Mrs. Cynthia Bradford Joslin, M.S.E. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1201 W Center St, Beebe, AR 72012 Phone: 501-882-5463 |
Calista Farinelli Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1001 Deese St, Beebe, AR 72012 Phone: 501-239-3353 Fax: 501-232-5057 |
Shelbey Lyn Haigwood, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 27 Hwy 64 W, Beebe, AR 72012 Phone: 501-230-3707 Fax: 501-882-9825 |
Mrs. Jenny Kay Roberson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 210 N Main St, Beebe, AR 72012 Phone: 501-882-2759 |
Carrie Ann Adele Willyard, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Akerman Ln, Bella Vista, AR 72714 Phone: 479-270-3720 Fax: 479-696-7779 |
Taylor Weston Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13 Bobwith Ln, Bella Vista, AR 72714 Phone: 619-569-6866 |
Mr. Barry Graf, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Blowing Springs Rd, Bella Vista, AR 72714 Phone: 479-696-3700 |
Mrs. Lezle Church Rupert, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Blowing Springs Rd, Bella Vista, AR 72714 Phone: 479-696-3700 |
Mrs. Kathleen R. Lancaster, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrod Dr, Bella Vista, AR 72714 Phone: 479-899-1458 |
Mrs. Andrea Hebar-hanson, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Blowing Springs Rd, Bella Vista, AR 72714 Phone: 479-696-3700 |
Mrs. Amanda Pullen, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Blowing Springs Rd, Bella Vista, AR 72714 Phone: 479-696-3700 |
Arkansas Therapy Outreach, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3851 Legacy Village Dr, Benton, AR 72015 Phone: 501-350-7572 Fax: 501-776-4059 |
Cassandra Powell, M.S.CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Park Dr, Benton, AR 72015 Phone: 501-315-0136 |
News Archive
BioCurex Inc. today announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer therapy. The test included samples from 27 human patients with early stages of breast cancer that were tested before and after surgery. As a control, 15 samples from healthy individuals were also tested.
Starting antiretroviral therapy early not only prevents serious AIDS-related diseases, but also prevents the onset of cancer, cardiovascular disease, and other non-AIDS-related diseases in HIV-infected people, according to a new analysis of data from the Strategic Timing of AntiRetroviral Treatment (START) study, the first large-scale randomized clinical trial to establish that earlier antiretroviral treatment benefits all HIV-infected individuals.
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced it had received clearance from the US Food and Drug Administration (FDA) to commence a phase 2 study to investigate VivaGelĀ® for the treatment of bacterial vaginosis (BV).
The Cedars-Sinai Heart Institute has been awarded a $1.66 million, four-year grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to develop a measurement system that could help doctors predict which patients could be struck by sudden cardiac arrest, a heart rhythm disturbance that causes instant death in more than 95 percent of cases.
› Verified 8 days ago